1. MARKETS
  2. SECTOR : OTHERS
  3. INDUSTRY : OTHERS
  4. RAPPORT THERAPEUTICS INC.
Rapport Therapeutics Inc. XNAS: RAPP

Rapport Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucid...

Read More
27.52 -0.59 (-2.10%)
34.89% Fall from 52W High
245.6K
XNAS Volume

XNAS 05 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Rapport Therapeutics Inc is on 14 Jan 2026 for the purpose of 44(th) Annual J.P. Morgan Healthcare Conference See details
Durability score
Not Eligible
Valuation Score
Expensive Valuation
9.7 / 100
Momentum Score
Technically Moderately Bullish
65.9 / 100
Analyst Price Target
No estimates available

6

S

10

W

3

O

1

T

SWOT Analysis

Rapport Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..